Legal status · Australia
Is GB-115 legal in Australia?
No. GB-115 is not an approved medicine in Australia; its classification is "Not approved; Schedule 4 or import-restricted". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
GB-115 in Australia at a glance
| Classification | Not approved; Schedule 4 or import-restricted |
|---|---|
| TGA approval status | Not approved by TGA |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the GB-115 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing GB-115 is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What GB-115 is
A Russian orally active dipeptide anxiolytic acting on the cholecystokinin system, launched by Western vendors in 2026 as a non-sedating benzodiazepine alternative; single-group animal data only.
GB-115 was developed at the Zakusov Institute as a CCK-4 analog with anxiolytic and antidepressant-like effects in rodents without sedation or dependence signals. No human trial has been published.
Mechanism: Modulation of cholecystokinin CCK receptors implicated in anxiety circuits.
Regulatory history: Not approved
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for GB-115 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
GB-115 in other countries
Frequently asked questions
Is GB-115 legal in Australia?
No. GB-115 is not an approved medicine in Australia; its classification is "Not approved; Schedule 4 or import-restricted". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
Can I buy GB-115 in Australia?
No approved product exists to buy. In Australia GB-115 is classified as "Not approved; Schedule 4 or import-restricted", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is GB-115 TGA approved?
No. In Australia GB-115 is classified as "Not approved; Schedule 4 or import-restricted", which is not a TGA marketing approval. For comparison, the US FDA status is: Not approved. Evidence level: Preliminary.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for GB-115 live on its compound profile.
GB-115 profileThis page is general information about the regulatory status of GB-115 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.